National Cancer Institute; Notice of Meeting, 6708 [05-2354]
Download as PDF
<![CDATA[
6708
Federal Register / Vol. 70, No. 25 / Tuesday, February 8, 2005 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 2, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2353 Filed 2–7–05; 8:45 am]
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.932, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 2, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2354 Filed 2–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
National Institutes of Health
National Cancer Institute; Notice of
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Director’s
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: February 28–March 1, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: 1. Reports from NCI: Health
Disparities; Planning; Survivorship; 2. Status
of NCI Listens and Learns Web Site; 3.
Listens and Learns Evaluation Plan and
Summit Evaluation Plan; 4. Listens and
Learns Working Group Meetings; 5. Meetings
with NCI Deputy Director; 6. Public
Comment; 7. Next steps.
Place: Holiday Inn Select Bethesda, 8120
Wisconsin Ave, Bethesda, MD 20814.
Contact Person: Nancy Caliman, Executive
Secretary, Office of Liaison Activities,
National Institutes of Health, National Cancer
Institute, 6116 Executive Boulevard, Suite
220, MSC8324, Bethesda, MD 20892, (301)
496–0307, calimann@mail.nih.gov.
This notice is to be published less than 15
days prior to the meeting due to scheduling
conflicts.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institutes’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
VerDate jul<14>2003
18:12 Feb 07, 2005
Jkt 205001
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 7–8, 2005.
Time: March 7, 2005, 8 a.m. to 10:30 a.m.
Agenda: Joint meeting of the NCI Board of
Scientific Advisors and NCI Board of
Scientific Counselors; Report of the Director,
NCI; Legislative Update; and Ethics
Overview.
Place: National Cancer Institute, Building
31, C Wing, 6 Floor, 9000 Rockville Pike,
Conference Room 10, Bethesda, MD 20892.
Time: March 7, 2005, 10:30 a.m. to 6 p.m.
Agenda: Ongoing and New Business;
Reports of Program Review Group(s); and
Budget Presentation; Reports of Special
Initiatives; RFA and RFP Concept Reviews;
and Scientific Presentations.
Place: National Cancer Institute, Building
31, C Wing, 6 Floor, 9000 Rockville Pike,
Conference Room 10, Bethesda, MD 20892.
Time: March 8, 2005, 8:30 a.m. to 1 p.m.
Agenda: Reports of Special Initiatives; RFA
and RFP Concept Reviews; and Scientific
Presentations.
Place: National Cancer Institute, Building
31, C Wing, 6 Floor, 9000 Rockville Pike,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Paulette S. Gray, PhD,
Executive Secretary, Acting Director,
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
Division of Extramural Activities, National
Cancer Institute, National Institutes of
Health, 6116 Executive Boulevard, 8th Floor,
Rm. 8001, Bethesda, MD 20892, 301–496–
5147.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into the building by non-government
employees. Persons without a government
I.D. will need to show a photo I.D. and signin at the security desk upon entering the
building.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/bsa.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 2, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2355 Filed 2–7–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel. TREC
Coordination Center.
Date: March 3, 2005.
E:\FR\FM\08FEN1.SGM
08FEN1
]]>Agencies
[Federal Register Volume 70, Number 25 (Tuesday, February 8, 2005)]
[Notices]
[Page 6708]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2354]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer
Liaison Group.
Date: February 28-March 1, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: 1. Reports from NCI: Health Disparities; Planning;
Survivorship; 2. Status of NCI Listens and Learns Web Site; 3.
Listens and Learns Evaluation Plan and Summit Evaluation Plan; 4.
Listens and Learns Working Group Meetings; 5. Meetings with NCI
Deputy Director; 6. Public Comment; 7. Next steps.
Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave,
Bethesda, MD 20814.
Contact Person: Nancy Caliman, Executive Secretary, Office of
Liaison Activities, National Institutes of Health, National Cancer
Institute, 6116 Executive Boulevard, Suite 220, MSC8324, Bethesda,
MD 20892, (301) 496-0307, calimann@mail.nih.gov.
This notice is to be published less than 15 days prior to the
meeting due to scheduling conflicts.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institutes's/Center's home
page: https://deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.932,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 2, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-2354 Filed 2-7-05; 8:45 am]
BILLING CODE 4140-01-M
